As of 2024-12-12, the Intrinsic Value of Relmada Therapeutics Inc (RLMD) is
-14.33 USD. This RLMD valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.42 USD, the upside of Relmada Therapeutics Inc is
-3,533.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.33 USD
Intrinsic Value
RLMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.33 - -14.33 |
-14.33 |
-3,533.14% |
| P/E |
(42.71) - (67.77) |
(67.51) |
-16270.1% |
| DDM - Stable |
(21.42) - (61.75) |
(41.58) |
-10060.3% |
| DDM - Multi |
(3.19) - (7.14) |
(4.41) |
-1156.2% |
RLMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
12.60 |
| Beta |
2.65 |
| Outstanding shares (mil) |
30.17 |
| Enterprise Value (mil) |
11.11 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.77% |
| Cost of Debt |
5.00% |
| WACC |
7.22% |